Schedule 13G ownership disclosure
PLX PHARMA INC. XXXBANKRUPTCY EFF: 10/02/23
Security class unavailable · CUSIP: 72942A107
Event date: 2020-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 970,425
- Percent of class
- 6.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001019056-21-000054
- Form type
- SC 13G
- Filer
- PLx Pharma Inc.
- CIK
- CIK 1497504
- Filed
- Jan 22, 2021
- Reporting period
- Dec 31, 2020
- Description
- Schedule 13G beneficial ownership